← All candidates
Four insider buys in the last year — $179.0K in all.
24 filings on record.
TLPHTALPHERA, INC.
NasdaqCM · Healthcare · $64.62M
$1.24
+1.64% · Sep 10
Four insider buys in the last year — $179.0K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 4 buys◆ 2 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$64.62M
Float
25.2M
49% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
64622.7
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
CHIEF EXECUTIVE OFFICER
Angotti Vincent J.
Bought $85.6K on Feb 12 — 105,364 sh @ $0.8123, held direct, 18% of their stake.
1 of 1 position beat the S&P
Chief Financial Officer
Asadorian Raffi
Bought $36.6K on Feb 12 — 45,000 sh @ $0.8123, held direct, 49% of their stake.
1 of 1 position beat the S&P
Chief Engineering Officer
Dasu Badri N
Bought $28.4K on Feb 12 — 35,000 sh @ $0.8123, held direct, 46% of their stake.
1 of 1 position beat the S&P
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
19 more transactions on Pro →Context
Wall St
$3.13 avg target
+152.0% vs today · 4 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
The file stays open
24 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice